Locoregional therapies for cholangiocarcinoma: Where they stand?
- PMID: 38775383
- DOI: 10.1111/liv.15901
Locoregional therapies for cholangiocarcinoma: Where they stand?
References
REFERENCES
-
- Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39:19‐31.
-
- Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557‐588.
-
- Forner A, Vidili G, Rengo M, Bujanda L, Ponz‐Sarvisé M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39:98‐107.
-
- Mauro E, Ferrer‐Fàbrega J, Sauri T, et al. New challenges in the management of cholangiocarcinoma: the role of liver transplantation, locoregional therapies, and systemic therapy. Cancers (Basel). 2023;15:1244.
-
- Vogel A, Bridgewater J, Edeline J, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up. Ann Oncol. 2023;34:127‐140.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources